5 unknown. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 5 |
| Phase 3 | 1 | Unknown 1 |
Follow Adjuvant Therapy: new trials by email Literature Review of Adjuvant Therapy trials Research Report on Adjuvant Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer Paclitaxel, Trastuzumab, Docetaxel - HER2-positive Breast Cancer, Adjuvant Therapy | Phase 2 / Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 190 | 2022-01-31 | 2022-01-12 |
| TQB2450 Plus Anlotinib as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Resection TQB2450 injection, Anlotinib hydrochloride capsules - Hepatocellular Carcinoma, Adjuvant Therapy | Phase 2 | Unknown | Xianhai Mao | 37 | 2022-01-06 | 2022-05-04 |
| A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection Tislelizumab, TACE - Hepatocellular Carcinoma, Adjuvant Therapy | Phase 2 | Unknown | Zhejiang University | 50 | 2021-11-08 | 2022-01-05 |
| Immunotherapy Versus Chemotherapy as Adjuvant Therapy for Colon Cancer With MSI-H or POLE/ POLD1 Mutations Tirelizumab - Immunotherapy, Adjuvant Therapy | Phase 2 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 30 | 2021-06-01 | 2021-07-20 |
| NAC Followed by RH for the Treatment of LACC Two cycles of neoadjuvant chemotherapy, First imaging evaluation, Second imaging evaluation - Neoadjuvant Chemotherapy, Locally Advanced Cervical Cancer | Phase 2 | Unknown | Lei Li | 60 | 2019-06-19 | 2019-06-20 |
Carcinoma, Hepatocellular (2) · Colonic Neoplasms (1) · Recurrence (1)
Digestive System Diseases (3) · Digestive System Neoplasms (3) · Neoplasms (3) · Neoplasms by Site (3) · Adenocarcinoma (2) · Carcinoma (2) · Liver Diseases (2) · Liver Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Disease Attributes (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1)
Chemoradiotherapy (1) · Docetaxel (1) · Immunotherapy (1) · Paclitaxel (1) · Protons (1) · Trastuzumab (1) · tislelizumab (1)
Lei Li (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Tianjin Medical University Cancer Institute and Hospital (1) · Xianhai Mao (1) · Zhejiang University (1)
China (5)
Lei Li, M.D. (1) · Tao Pan (1) · Yi Ba, MD (1)